<?xml version="1.0" encoding="UTF-8"?>
<p>Inadequacy of clinical results should be due to the different doses used in preclinical studies, wherein often high fatty acids levels were administered; moreover, other factors such as genetic and epigenetic heterogeneity of the recruited subjects, diet diversity, nutritional habits and microbiome can be considered as additional confounding factors [
 <xref rid="B49-vaccines-08-00468" ref-type="bibr">49</xref>]. 
</p>
